T-Cell Project: Epidemiologic Component
- The T-Cell Project, sponsored by the International T-cell non-Hodgkin Lymphoma Study Group, is a consortium of institutions interested in achieving more detailed information on clinical and biological characteristics of T-cell lymphomas.
- The T-Cell Project serves as a repository for data on patients with peripheral T-cell lymphoma (PTCL) worldwide. Its overall goal is to improve T-cell subtype classifications and evaluate treatment strategies for each subtype.
-To implement a standardized epidemiologic questionnaire into the ongoing T-Cell Project to allow evaluation of various potential risk factors for PTLCs.
-Untreated patients 18 years of age and older who were diagnosed with PTLC September 1, 2006, or later.
-Patients complete a questionnaire containing the following information:
Smoking history and alcohol use
Personal history or cancer
History of cancer among first-degree relatives
History of transplants
History of blood transfusions
Occupational and residential history
-The information collected is linked to clinical and pathologic information in the T-Cell Project database.
Peripheral T-Cell Lymphoma
|Study Design:||Time Perspective: Prospective|
|Official Title:||T-Cell Project: Epidemiologic Component|
|Study Start Date:||June 18, 2008|
|Estimated Study Completion Date:||July 20, 2011|
Please refer to this study by its ClinicalTrials.gov identifier: NCT00705809
|United States, Maryland|
|National Cancer Institute (NCI), 9000 Rockville Pike|
|Bethesda, Maryland, United States, 20892|